Q2 2021 13F Holders as of 30 Jun 2021
-
Type / Class
-
Equity / Common Stock, $0.0001 par value
-
Shares outstanding
-
2,534,263
-
Number of holders
-
51
-
Total 13F shares, excl. options
-
27,563,135
-
Shares change
-
+27,563,135
-
Total reported value, excl. options
-
$757,432,770
-
Value change
-
+$757,432,726
-
Number of buys
-
51
-
Price
-
$27.48
Significant Holders of Singular Genomics Systems, Inc. - Common Stock, $0.0001 par value (OMIC) as of Q2 2021
51 filings reported holding OMIC - Singular Genomics Systems, Inc. - Common Stock, $0.0001 par value as of Q2 2021.
Singular Genomics Systems, Inc. - Common Stock, $0.0001 par value (OMIC) has 51 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 27,563,135 shares
.
Largest 10 shareholders include DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) (9,112,019 shares), PERCEPTIVE ADVISORS LLC (3,082,870 shares), Casdin Capital, LLC (2,692,870 shares), FMR LLC (2,119,615 shares), COATUE MANAGEMENT LLC (2,119,614 shares), ORBIMED ADVISORS LLC (1,998,521 shares), GOLDMAN SACHS GROUP INC (981,681 shares), VANGUARD GROUP INC (755,892 shares), Alphabet Inc. (646,622 shares), and Nicholas Investment Partners, LP (629,716 shares).
This table shows the top 51 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.